LEP and ovarian serous adenocarcinoma: Although patients’ leptin levels were similar to healthy women in the study of Vysotskii et al. (2009), leptin levels in patients with poorly and moderately differentiated serous ovarian cancer were 2-fold higher than in well-differentiated tumours.